Consequently, FMR1 loss impairs binding to m6A‐marked ADAM17 mRNA and recruitment of decay complexes, stabilizing ADAM17 transcripts, increasing protein levels, and enhancing angiogenesis in ccRCC cells. This evidence concerns the gene ADAM17 and nonpapillary renal cell carcinoma.